– UK, London – Tyman Plc (LON: TYMN), a leading international supplier of engineered components and access solutions to the construction industry, today announced the appointment of Dr Paul Withers as a Non-Executive Director with effect from 1 February 2020.
“I am delighted to welcome Paul as the next Chair of the Remuneration Committee and SID. Paul’s breadth of experience in international manufacturing businesses, coupled with strategic insight gained from his extensive career, making him an excellent addition to our Board,” said Martin Towers, Chair of Tyman.
Paul will succeed Mark Rollins, who will be stepping down from the Board on 31 March 2020, and will take over the roles of Chairman of the Remuneration Committee and Senior Independent Director from that date. Paul will join the Audit, Nomination and Remuneration Committees with effect from the date of his appointment to the Board on 1 February 2020.
“I also would like to thank Mark for his wise counsel and significant contribution to the Company during his five years on the Board. Mark will depart with the Board’s very best wishes for the future.”
About Dr Paul Withers
Paul brings extensive international experience and in particular strong knowledge of US markets to the Board, both as an executive and non-executive director. He is SID and Chair of the Remuneration Committee for both Keller Group plc and Devro plc. Paul’s executive career was spent at BPB plc, the international building materials business where he was Group Managing Director. He has also been a Non-Executive Director, SID and Chair of the Remuneration Committee of both Premier Farnell plc and Hyder Consulting plc.
For more information: https://www.tymanplc.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
Comments are closed.